CBD oil pictured with an article about peripheral neuropathy research

CBD for Neuropathy in Feet UK: What Does the Research Show?

February 15, 2026

Can CBD Help Neuropathy in the Feet?

CBD is frequently discussed online as a possible option for nerve pain, tingling, burning and numbness in the feet.

There is genuine human research in this area, but the results are mixed.

A small placebo-controlled study of topical CBD reported improvements in several symptoms of peripheral neuropathy. A much larger randomized trial of oral CBD found no reduction in peripheral neuropathic pain compared with placebo. A later trial of a topical CBD-isolate cream for chemotherapy-induced neuropathy was also negative.

More recently, a 2026 clinical trial found a modest reduction in neuropathic pain with very high-dose oral CBD in people with spinal cord injury — but that study involved a different type of neuropathic pain and doses of up to 800mg CBD per day.

So the most accurate answer is:

CBD remains an active area of neuropathic-pain research, but current evidence does not establish ordinary retail CBD oil as a treatment for peripheral neuropathy in the feet.

It is especially important not to turn individual positive studies into promises that CBD repairs damaged nerves, stops burning feet or restores mobility.

What Is Peripheral Neuropathy?

Peripheral neuropathy occurs when nerves outside the brain and spinal cord become damaged.

The peripheral nerves connect the central nervous system to the rest of the body and carry several different kinds of signals.

These include:

sensation
pain
touch
temperature
muscle control
certain automatic bodily functions.

The NHS explains that peripheral neuropathy commonly affects the hands and feet.

Typical symptoms can include:

numbness
pins and needles
burning sensations
stabbing or shooting pain
sensitivity to touch
loss of balance
muscle weakness.

Polyneuropathy, which affects many nerves, commonly begins in the longest nerves first. This is one reason symptoms often start in the feet before progressing upwards. Read NHS information on peripheral neuropathy.

Why Is Neuropathy in the Feet Important to Diagnose?

Tingling or burning feet can have many different causes.

Peripheral neuropathy can be associated with:

diabetes
vitamin B12 deficiency
physical nerve injury
shingles
some medicines
excessive alcohol use
other neurological or medical conditions.

Diabetes is the most common cause of peripheral neuropathy in the UK.

That makes diagnosis important.

A CBD article should not encourage somebody to assume that unexplained burning or numbness is simply a symptom to mask.

The NHS advises seeing a GP if someone develops early symptoms such as pain, tingling or loss of sensation in the feet, weakness or balance problems.

It specifically highlights a cut or ulcer on the foot that is not healing, because reduced sensation can allow injuries to become more serious without being noticed.

How Is Peripheral Neuropathy Diagnosed?

Diagnosis usually involves identifying both the nerve problem and its underlying cause.

A GP may examine:

sensation
reflexes
muscle strength
the distribution of symptoms.

Blood tests may be used to look for causes such as diabetes or vitamin B12 deficiency.

Some people are referred to a neurologist for tests including nerve-conduction studies and electromyography. Read NHS information on diagnosing peripheral neuropathy.

This matters when considering CBD because neuropathy is not one single disease.

A treatment studied for neuropathy caused by one condition should not automatically be assumed to work for neuropathy caused by another.

Why Has CBD Been Studied for Neuropathic Pain?

Neuropathic pain behaves differently from many other forms of pain.

It results from abnormal or damaged nerve signalling rather than simply tissue injury.

Researchers have therefore investigated several cannabinoid-related mechanisms, including possible effects on:

pain signalling
sensory processing
inflammatory pathways
cannabinoid receptors
other signalling systems involved in nerve activity.

These mechanisms provide reasons for conducting clinical trials.

However, they do not prove that CBD reduces nerve pain in humans.

This distinction is important.

Laboratory evidence can tell researchers what may be worth investigating. Clinical trials are needed to determine whether those mechanisms actually produce meaningful benefits for patients.

Our separate CBD and Inflammation UK article examines why inflammatory mechanisms should not automatically be converted into consumer treatment claims.

What Did the 2020 Topical CBD Neuropathy Study Find?

One of the most frequently cited CBD studies in this area was published in 2020.

It involved 29 people with symptomatic peripheral neuropathy of the lower extremities.

Fifteen participants received a topical product containing CBD and 14 received placebo.

The study lasted four weeks before the placebo group was allowed to cross over to CBD treatment.

The researchers reported statistically significant differences favouring CBD for several measures, including:

intense pain
sharp pain
cold sensations
itching.

No adverse events were reported in that study. Read the 2020 study on PubMed.

This is an interesting positive result.

But there are important limitations.

The trial was very small: only 29 people in total, with 15 initially receiving CBD.

It also tested a particular topical preparation containing 250mg CBD in a three-fluid-ounce container.

It did not test Valley CBD oil.

It did not establish that swallowing CBD oil produces the same result.

And a four-week trial involving fewer than 30 people is not strong enough on its own to establish CBD as a standard treatment for peripheral neuropathy.

What Did the Larger Oral-CBD Trial Find?

A larger randomized, double-blind clinical trial gives us an important counterbalance.

Researchers studied people with painful peripheral neuropathy who had already failed at least one evidence-based neuropathic-pain treatment.

Participants received:

CBD
THC
CBD + THC
placebo.

CBD doses ranged from 5mg to 50mg.

The study included 118 randomized participants, with 115 included in the intention-to-treat analysis.

The result was clear:

CBD did not reduce peripheral neuropathic pain compared with placebo.

Neither THC nor the CBD+THC combination produced a significant pain reduction compared with placebo in this particular trial either. Read the randomized trial on PubMed.

This is especially important for an article about CBD oil because it directly challenges the idea that simply taking more CBD will necessarily calm damaged nerves.

What Did the 2024 CBD-Isolate Cream Study Find?

Another useful study was published in 2024 and investigated chemotherapy-induced peripheral neuropathy.

Forty participants with established chemotherapy-induced neuropathy were randomized to receive a topical CBD product or placebo.

The CBD preparation used CBD isolate.

Researchers compared several neuropathy measures.

The scores were similar during CBD and placebo treatment, and the study concluded that the particular CBD-isolate cream tested did not improve established painful chemotherapy-induced peripheral neuropathy. Read the 2024 study on PubMed.

This is particularly relevant when discussing extract type.

It would be wrong to say:

“CBD isolate is better for neuropathy because it is purer.”

Purity and clinical effectiveness are different questions.

The 2024 trial specifically studied an isolate formulation and did not demonstrate the claimed benefit.

What About the New 2026 High-Dose CBD Study?

In 2026, researchers published another randomized, double-blind, placebo-controlled CBD trial.

This time, participants had chronic neuropathic pain associated with spinal cord injury.

Forty people were randomized and 38 were included in the primary analysis.

CBD was gradually increased to doses of up to 800mg per day.

During the active treatment phase, average pain intensity was modestly lower with CBD than placebo, with an average difference of approximately 0.54 points on a 0–10 pain scale.

The researchers concluded that high-dose CBD reduced self-reported neuropathic pain, although the effect was modest. Read the 2026 study on PubMed.

That is an important study and should not be ignored.

But it requires careful interpretation.

It was not ordinary peripheral neuropathy of the feet

Neuropathic pain caused by spinal cord injury is not the same condition as peripheral polyneuropathy caused by diabetes, vitamin deficiency or peripheral nerve damage.

It used pharmacological CBD doses

Participants were titrated as high as 800mg CBD per day.

That is vastly different from UK consumer CBD-food guidance.

It does not establish a retail CBD dose

The study cannot reasonably be converted into advice such as:

“Take high-strength CBD oil for neuropathy.”

It instead tells us that high-dose CBD deserves further clinical investigation for particular forms of neuropathic pain.

What Does the Broader Cannabinoid Evidence Show?

A systematic review published in 2025 examined 14 randomized controlled trials of cannabinoids for peripheral neuropathy and neuropathic pain.

Thirteen of the 14 included studies reported a statistically significant reduction in neuropathic pain in at least one cannabinoid treatment.

A meta-analysis of seven studies found an average improvement of approximately 0.67 points on a 0–10 pain scale compared with placebo. Read the 2025 systematic review on PubMed.

That sounds encouraging, but there is an important distinction.

The review concerned cannabinoids and cannabis-based medicines broadly.

It was not evidence that pure oral CBD isolate consistently produces that effect.

Studies involving:

THC
CBD
THC+CBD
cannabis preparations
different delivery methods

cannot all be treated as if they tested the same product.

The review itself says the role of cannabis-based medicines for peripheral neuropathic pain has not been definitively established.

So Is the Evidence for CBD Positive or Negative?

It is genuinely mixed.

We have:

A small positive topical CBD study involving 29 people.

A substantially larger negative oral CBD trial involving 115 people in the main analysis.

A negative topical CBD-isolate trial involving 40 people with chemotherapy-induced neuropathy.

A positive but modest 2026 high-dose oral CBD trial involving neuropathic pain after spinal cord injury rather than ordinary peripheral neuropathy.

And a broader cannabinoid systematic review suggesting a small average benefit across mixed cannabinoid treatments.

That is why a simple claim such as “CBD works for nerve pain” is not justified.

Can CBD Repair Damaged Nerves?

There is no good clinical evidence establishing that retail CBD oil repairs or regenerates damaged peripheral nerves.

Reducing a symptom in a pain study would not necessarily mean the underlying nerve damage had healed.

Those are two very different outcomes.

The old Valley CBD article described CBD as targeting overactive nerves and helping restore comfort and mobility. The evidence does not support presenting CBD as a nerve-repair treatment.

Can CBD Stop Burning or Tingling in the Feet?

The small 2020 topical study reported improvements in several sensory symptoms, including sharp pain, cold sensations and itching.

However, larger or later controlled CBD studies have not consistently reproduced a benefit.

Therefore, it would be inappropriate to promise that CBD stops:

burning
pins and needles
numbness
tingling
stabbing nerve pain.

People experiencing these symptoms should first consider the underlying cause with an appropriate healthcare professional.

CBD Oil or CBD Balm for Neuropathy?

The existing scientific literature includes both swallowed and topically applied cannabinoids.

But different formulations cannot simply be substituted for one another.

A trial of topical CBD does not prove that oral CBD oil works.

Likewise, a study involving oral CBD does not establish that a CBD balm applied to the feet will have the same effects.

Even topical products vary considerably in:

CBD concentration
other ingredients
formulation
skin penetration
application frequency.

So neither Valley CBD oil nor Valley CBD balm should be described as a proven neuropathy treatment based on these studies.

Is Higher-Strength CBD Better for Neuropathy?

There is currently no reliable evidence demonstrating that a stronger retail CBD concentration provides better neuropathy outcomes.

Strength simply describes how concentrated the CBD is.

For example, a 40% CBD oil contains more CBD per unit volume than a 10% CBD oil.

That does not establish:

greater nerve-pain relief
better nerve repair
improved mobility
faster results.

The old article repeatedly linked high strength with stronger nerve support. The new evidence-led position keeps concentration and medical effectiveness separate.

Is CBD Isolate Better for Neuropathy?

There is also no convincing evidence that CBD isolate is clinically superior to broad-spectrum or full-spectrum products for peripheral neuropathy.

Valley CBD uses CBD isolate.

That can be stated as a factual description of the product.

But it should not be converted into:

“CBD isolate is the gold standard for neuropathy.”

The 2024 chemotherapy-neuropathy trial is especially useful here because the researchers tested a CBD-isolate topical preparation and did not demonstrate an improvement compared with placebo.

What About Diabetic Neuropathy?

Diabetes is the most common cause of peripheral neuropathy in the UK.

Long-term high blood glucose can damage nerves, particularly those supplying the feet.

That is why somebody searching for CBD for neuropathy may also have diabetes.

Our separate CBD and Diabetes UK article examines CBD and diabetes research in more detail.

For this article, the important point is that diabetic neuropathy is a complication of an underlying medical condition.

A CBD product should not be presented as a substitute for appropriate diabetes management or neuropathy treatment.

Can Neuropathy Get Worse if the Cause Is Not Treated?

Yes, depending on the cause.

The NHS explains that some forms of peripheral neuropathy can improve if their underlying cause is treated, while other nerve damage may be permanent or progressively worsen.

Untreated loss of sensation in the feet can also increase the risk of wounds and ulcers going unnoticed.

In severe cases, infected ulcers can lead to serious complications.

This is another reason why an educational article about neuropathy should emphasise diagnosis rather than simply recommending a pain product.

What Treatments Are Used for Neuropathic Pain?

Treatment depends partly on what caused the neuropathy.

For example:

controlling diabetes may help prevent further diabetic nerve damage
vitamin B12 deficiency can be treated
medicine-induced neuropathy may improve if the responsible medicine can safely be changed.

For neuropathic pain itself, the NHS lists medicines including:

amitriptyline
duloxetine
pregabalin
gabapentin.

These medicines are different from ordinary painkillers because neuropathic pain often responds poorly to drugs such as paracetamol or ibuprofen. Read NHS peripheral neuropathy treatment guidance.

Current NICE guidance similarly recommends a choice of amitriptyline, duloxetine, gabapentin or pregabalin as initial pharmacological treatment for most neuropathic pain in non-specialist settings. Read NICE neuropathic pain guidance.

CBD food supplements are not included as a standard first-line neuropathic-pain treatment.

Our broader CBD Oil and Pain UK guide examines the wider human evidence around CBD and pain.

Can CBD Be Taken With Neuropathy Medication?

CBD can interact with medicines.

Many people with peripheral neuropathy may already take medicines for:

neuropathic pain
diabetes
blood pressure
cardiovascular disease
other underlying conditions.

The Food Standards Agency's current position is particularly relevant.

It says CBD is not recommended for people taking medication unless under medical direction.

The FSA also advises people with underlying health conditions to avoid consuming CBD unless under medical direction. Read current FSA guidance.

So a CBD retailer should not provide individual advice about combining CBD with gabapentin, pregabalin, duloxetine or another medicine.

How Much CBD Should Someone Take for Neuropathy?

There is no established retail CBD treatment dose for peripheral neuropathy.

Clinical research doses should not be converted into consumer recommendations.

This is particularly important because studies have used dramatically different amounts.

The large oral peripheral-neuropathy trial studied CBD doses from 5–50mg.

The 2026 spinal-cord-injury trial titrated participants to as much as 800mg per day.

Neither establishes how much a UK consumer should take for neuropathy.

For CBD sold as food, the FSA currently recommends a maximum daily intake of 10mg CBD per day for healthy adults.

This is consumer-safety guidance, not a neuropathy-treatment dose.

The FSA also advises avoidance for certain groups, including people taking medication, unless under medical direction.

Does the FSA Say CBD Is Proven to Help Pain?

No.

The FSA addressed this question directly in June 2026.

It states that there are no proven health or medical benefits for CBD food products in relation to areas such as pain, anxiety or sleep and that claims that CBD foods relieve pain or treat illness are not permitted.

It also states that there are currently no authorised health claims for CBD food products.

Therefore, statements such as:

“CBD relieves neuropathy”
“CBD targets damaged nerves”
“CBD reduces nerve inflammation”
“CBD restores mobility”
“high-strength CBD provides ongoing nerve relief”

should not be used to market a CBD food product.

Is Research CBD the Same as a Retail CBD Product?

Not necessarily.

Clinical studies may use:

pharmaceutical-grade CBD
specially prepared topical formulations
carefully controlled doses
CBD combined with THC
very high doses
medical supervision.

A retail CBD oil is not automatically equivalent to the treatment tested in a clinical trial.

This is especially obvious in the 2026 trial, where participants received up to 800mg oral CBD per day under research conditions.

That study should not be used to imply that buying a stronger bottle of consumer CBD recreates the clinical experiment.

Frequently Asked Questions

Can CBD oil help neuropathy in the feet?

Research has investigated CBD and neuropathic pain, but the evidence is mixed.

A small topical study produced positive results, while a larger oral-CBD study found no improvement over placebo.

Retail CBD oil is not established as a treatment for peripheral neuropathy.

Does CBD help nerve pain?

CBD has been studied for neuropathic pain, but results vary depending on the condition, formulation and study.

The evidence does not currently justify promising that ordinary CBD oil relieves nerve pain.

Can CBD repair damaged nerves?

There is no good clinical evidence showing that retail CBD oil repairs or regenerates damaged peripheral nerves.

Symptom reduction and nerve repair are different medical outcomes.

Can CBD stop tingling or burning feet?

One small topical study reported improvements in certain neuropathy symptoms, but controlled research has not consistently shown that CBD stops burning or tingling.

Those symptoms can also indicate an underlying condition that requires diagnosis.

Is CBD oil or CBD balm better for neuropathy?

There is insufficient evidence to say one is better.

Oral and topical studies involve very different formulations and cannot automatically be applied to retail CBD oils or balms.

Is high-strength CBD better for neuropathy?

There is no reliable evidence demonstrating that a higher retail CBD concentration produces better neuropathy outcomes.

Higher concentration means more CBD per volume, not proven greater medical effectiveness.

Is CBD isolate better for neuropathy?

There is no convincing evidence that CBD isolate is clinically superior for neuropathy.

Valley CBD uses isolate, but that should not be described as a treatment advantage.

What did the largest direct oral-CBD study find?

A randomized trial with 115 participants in the main analysis found that oral CBD did not reduce peripheral neuropathic pain compared with placebo.

What did the 2026 CBD study find?

A 2026 trial found a modest reduction in chronic neuropathic pain associated with spinal cord injury using high-dose CBD.

However, the condition was different from ordinary peripheral neuropathy and CBD was titrated up to 800mg per day.

What should someone do about unexplained numbness or tingling in their feet?

The NHS recommends speaking to a GP about early symptoms of peripheral neuropathy, particularly pain, tingling or loss of sensation in the feet, balance problems, weakness, or a foot wound that is not healing.

Can CBD replace neuropathy medication?

No.

Retail CBD should not be presented as a replacement for prescribed neuropathic-pain treatment or treatment of the underlying cause.

How much CBD should I take for neuropathy?

There is no established consumer CBD treatment dose for neuropathy.

The FSA currently advises healthy adults consuming CBD foods not to exceed 10mg CBD per day, and this is safety guidance rather than a treatment dose.

The Bottom Line

Peripheral neuropathy is a complex group of nerve disorders with many possible causes.

CBD is a legitimate research subject in neuropathic pain, and the evidence should not be dismissed.

A small topical trial reported promising results.

A broader systematic review of cannabinoid treatments found a modest average reduction in neuropathic pain.

A new 2026 trial found a modest benefit from very high-dose CBD in spinal-cord-injury-associated neuropathic pain.

But there is another side to the evidence.

A larger randomized trial found that oral CBD did not reduce peripheral neuropathic pain compared with placebo, and a 2024 placebo-controlled CBD-isolate cream trial found no improvement in established chemotherapy-induced neuropathy.

So the available research does not support promising that Valley CBD oil:

calms damaged nerves
repairs neuropathy
reduces burning or tingling
restores mobility
lowers nerve inflammation
works better at higher strengths.

People experiencing new or unexplained neuropathy symptoms should seek appropriate medical assessment, particularly because identifying and treating the underlying cause can sometimes prevent further nerve damage.

This article is for general educational information only and is not medical advice. Valley CBD products are not intended to diagnose, treat, cure or prevent disease.

Sources

Back to blog

Country/region